Skip to main content
. 2018 Nov 21;38(47):10168–10179. doi: 10.1523/JNEUROSCI.3411-17.2018

Figure 2.

Figure 2.

IL-2/IL-2Ab treatment has little influence on non-Treg populations. A, Gating strategy for CD3B220+ B cells, CD3+CD4+ T cells, CD3+CD8+ T cells, NK1.1+ NK cells, Gr1+ neutrophils, and CD115+ monocytes. BE, Percentages of peripheral B cells, CD4+ T cells, CD8+ T cells, NK cells, neutrophils, and monocytes in blood (B, C) and spleen (D, E) showed no change after IL-2/IL-2Ab treatment. n = 5–9/group.